Related Experiment Video
Updated: Jan 5, 2026
08:15
Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
954
A small molecule protects mitochondrial integrity by inhibiting mTOR activity
Ran Cao1,2,3, Li Li2,3, Zhengxin Ying2,3
1School of Life Sciences, Peking University, 100871 Beijing, China.
Summary
Researchers discovered Compound R6, a novel apoptosis inhibitor that protects cells from mitochondrial damage. This compound shows promise for neurodegenerative diseases by crossing the blood-brain barrier and exhibiting neuroprotective effects.
Area of Science:
- Cellular Biology
- Neuroscience
- Pharmacology
Background:
- Apoptosis, triggered by cytochrome c release, is a cellular response to mitochondrial damage.
- Small molecules can inhibit apoptosis and protect cells from mitochondrial damage.
- Compound A previously showed neuroprotection in Parkinson's disease models by targeting mitochondrial complex II.
Purpose of the Study:
- To identify and characterize novel small-molecule apoptosis inhibitors.
- To investigate the mechanism of action of Compound R6.
- To evaluate the therapeutic potential of Compound R6 for neurodegenerative diseases.
Main Methods:
- Cellular apoptosis assays were used to screen for apoptosis inhibitors.
- Compound R6's mechanism was studied via mammalian target of rapamycin (mTOR)-mediated autophagy induction.
- Pharmacokinetic profiling and a rat cerebral ischemia/reperfusion model were employed.
Main Results:
- Compound R6 inhibits apoptosis by inducing autophagy via mTOR.
- Compound R6 preserves mitochondrial integrity and respiration during intrinsic apoptosis.
- Compound R6 is metabolically stable, crosses the blood-brain barrier, and accumulates in the brain.
- Compound R6 demonstrated significant neuroprotection in a cerebral ischemia/reperfusion model.
Conclusions:
- Compound R6 is a novel apoptosis inhibitor with a distinct mechanism involving mTOR-mediated autophagy.
- Compound R6 possesses favorable pharmacokinetic properties, including brain penetration.
- Compound R6 shows significant neuroprotective potential, warranting further investigation as a therapeutic agent for neurodegenerative diseases.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:19Translocation of Proteins into the Mitochondria
11.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.8K
01:45Mitochondrial Membranes
16.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.5K
01:46Electron Transport Chain: Complex I and II
18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
01:28The Inner Mitochondrial Membrane
4.4K
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
4.4K